Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Thyrocare Technologies Limited
THYROCARE | NSE
395.10
INR-0.05
-0.01%
THYROCARE | NSE
Loading StockChartView...
About Thyrocare Technologies Limited
Sector
Healthcare
Industry
Diagnostics & Research
Earnings date
31/03/2024
As of date
24/04/2026
Close
395.10
Open
395.00
High
403.10
Low
389.00
Thyrocare Technologies Limited provides diagnostic testing services to patients laboratories and hospitals in India. It operates in three segments: Diagnostic Testing Services Imaging Services and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases including thyroid growth metabolism auto-immunity diabetes anaemia cardiovascular infertility COVID and various infectious diseases. Its profiles of tests include 34 profiles of tests administered under its Aarogyam brand which offers patients a suite of wellness and preventive health care tests. The company also sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.
View LessTHYROCARE | NSE
Risk
29.5
Sharpe
1.67
Luna's Score
64/100
Recommendation
Hold
Luna says (THYROCARE | NSE)
What's Working
Good Dividend Yield (2% <= Dividend Yield <= 8%)
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
What's not Working
Weakness based on declining price with high volume
Microcap (<300M USD)
Rich in Valuation (Price to Book > 8)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
18.6%1 month
29.5%3 months
37.4%6 months
40.3%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
59.87
Fwd. PE
-
Price to book
8.83
Debt to equity
0.08
Debt to assets
0.07
Ent. to EBITDA
30.88
Ent. to rev.
7.95
PEG
-
Other Fundamentals
EBITDA
1.48B
MarketCap
20.92B
MarketCap(USD)
219.39M
Div. yield
2.04
Op. margin
19.94
Erngs. growth
38.80
Rev. growth
16.30
Ret. on equity
13.08
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
27.45
Range1M
64.20
Range3M
126.45
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.01
Price X volume
100.12M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 30.88 | 22.78 | Expensive |
| Ent. to Revenue | 7.95 | 6.55 | Expensive |
| PE Ratio | 59.87 | 51.14 | Par |
| Price to Book | 8.83 | 6.69 | Expensive |
| Dividend Yield | 2.04 | 0.94 | Leader |
| Std. Deviation (3M) | 37.41 | 32.84 | Par |
| Debt to Equity | 0.08 | 0.18 | Cheaper |
| Debt to Assets | 0.07 | 0.12 | Cheaper |
| Market Cap | 20.92B | 60.74B | Emerging |
